Cancer Association of Botswana
This article needs additional citations for verification. (September 2009) |
Abbreviation | CAB |
---|---|
Formation | 1998 |
Type | non-governmental organization |
Cancer Association of Botswana (CAB) is a volunteer run, non-governmental organization established as a trust in 1998. They are dedicated to reducing the impact of cancer on all affected in Botswana.[citation needed]
Mission
Cancer Association of Botswana is dedicated to reducing the impact of cancer on all affected in Botswana[1] by increasing awareness and education to promote healthy lifestyles and early detection of cancer, facilitating medical care and providing counseling and support to those affected.
Programs
- Awareness
CAB promotes prevention and health promotion through talks, conferences, campaigns and the distribution of brochures and posters throughout the country.[2]
- Care
Through Tshiamo House (the Interim Care Home) temporary accommodation, medical care, and meals are provided to patients while they are receiving treatment at
- Support
CAB offers free, confidential counseling to patients, family, and friends. After-care is also offered to patients after returning to their respective homes through follow up telephone calls and home visits.
- Reach for Recovery
CAB has a group of survivors who visit cancer patients at their homes and provide them with emotional and spiritual support. This allows for a process whereby cancer victims transform into cancer survivors through active, optimistic and healthy outlook and lifestyle.[citation needed]
References
- ^ Union for International Cancer Control reference page on Cancer Association of Botswana
- ^ "Cancer Association of Botswana | UICC". www.uicc.org. Retrieved 2021-02-04.
External links
- Official website
- https://www.sundaystandard.info/cancer-association-of-botswana-launches-website/
- Suneja, Gita; Ramogola-Masire, Doreen; Medhin, Heluf G; Dryden-Peterson, Scott; Bekelman, Justin E (July 2013). "Cancer in Botswana: resources and opportunities". The Lancet Oncology. 14 (8): e290–e291. PMID 23816293.